Buyer Name: MEDICINES DISCOVERY CATAPULT LIMITED
Buyer Address: Block 35g, Mereside Alderley Park, Macclesfield, UKD62, SK10 4ZF, United Kingdom
Contact Email: procurement@md.catapult.org.uk
Buyer Name: MEDICINES DISCOVERY CATAPULT LIMITED
Buyer Address: Block 35g, Mereside Alderley Park, Macclesfield, UKD62, SK10 4ZF, United Kingdom
Contact Email: procurement@md.catapult.org.uk
..
No linked documents found for this notice.
Lot 1 Status: complete
Document Description: Not published
{
"awards": [
{
"aboveThreshold": true,
"contractPeriod": {
"endDate": "2026-12-17T23:59:59Z",
"maxExtentDate": "2030-12-18T23:59:59Z",
"startDate": "2025-12-17T00:00:00Z"
},
"documents": [
{
"datePublished": "2025-12-08T14:22:22Z",
"description": "Transparency notice on Find a Tender",
"documentType": "awardNotice",
"format": "text/html",
"id": "080646-2025",
"noticeType": "UK5",
"url": "https://www.find-tender.service.gov.uk/Notice/080646-2025"
}
],
"hasOptions": true,
"hasRenewal": true,
"id": "1",
"items": [
{
"additionalClassifications": [
{
"description": "Laboratory, optical and precision equipments (excl. glasses)",
"id": "38000000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UK"
}
],
"id": "1",
"relatedLot": "1"
}
],
"mainProcurementCategory": "goods",
"milestones": [
{
"dueDate": "2025-12-17T23:59:59Z",
"id": "1",
"status": "scheduled",
"type": "futureSignatureDate"
}
],
"options": {
"description": "The contract may be extended to purchase four 12 month warranty extensions."
},
"relatedLots": [
"1"
],
"renewal": {
"description": "The contract may be extended for a further four twelve month periods to extend the original warranty."
},
"status": "pending",
"suppliers": [
{
"id": "GB-PPON-PBMJ-4568-WMPX",
"name": "10x Genomics Inc"
}
],
"value": {
"amount": 344000,
"amountGross": 412800,
"currency": "GBP"
}
}
],
"buyer": {
"id": "GB-COH-09928547",
"name": "MEDICINES DISCOVERY CATAPULT LIMITED"
},
"date": "2025-12-08T14:22:22Z",
"id": "080646-2025",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-05f0dd",
"parties": [
{
"additionalIdentifiers": [
{
"id": "PJPQ-6911-DQYY",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Macclesfield",
"postalCode": "SK10 4ZF",
"region": "UKD62",
"streetAddress": "Block 35g, Mereside Alderley Park"
},
"contactPoint": {
"email": "procurement@md.catapult.org.uk"
},
"details": {
"classifications": [
{
"description": "Public authority - sub-central government",
"id": "publicAuthoritySubCentralGovernment",
"scheme": "UK_CA_TYPE"
}
]
},
"id": "GB-COH-09928547",
"identifier": {
"id": "09928547",
"scheme": "GB-COH"
},
"name": "MEDICINES DISCOVERY CATAPULT LIMITED",
"roles": [
"buyer"
]
},
{
"address": {
"country": "US",
"countryName": "United States",
"locality": "Pleasanton",
"postalCode": "CA 94588-3260",
"region": "US",
"streetAddress": "6230 Stoneridge Mall Road"
},
"contactPoint": {
"email": "tenders@10xgenomics.com"
},
"details": {
"scale": "large",
"url": "https://www.10xgenomics.com/",
"vcse": false
},
"id": "GB-PPON-PBMJ-4568-WMPX",
"identifier": {
"id": "PBMJ-4568-WMPX",
"scheme": "GB-PPON"
},
"name": "10x Genomics Inc",
"roles": [
"supplier"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"description": "..",
"documents": [
{
"description": "Not published",
"documentType": "conflictOfInterest",
"id": "conflictOfInterest"
}
],
"id": "ocds-h6vhtk-05f0dd",
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"lots": [
{
"id": "1",
"status": "complete"
}
],
"procurementMethod": "direct",
"procurementMethodDetails": "Direct award",
"procurementMethodRationale": "Medicines Discovery Catapult (MDC) intends to award a contract for the purchase of a Xenium single-cell spatial transcriptomics/proteomics instrument to 10X Genomics, on the basis that no reasonable alternative or substitute exists which meets the specific technical and operational requirements of the organisation.\nIndependent comparative studies have demonstrated that alternative platforms currently on the market exhibit significantly higher levels of background noise, reducing data quality in single cell spatial analysis. MDC has verified these performance results and determined that the Xenium system is uniquely capable of delivering the sensitivity and precision required for our research and service activities.\nBeyond this the Xenium platform also offers operational advantages. It enables the use of panels with a low minimum run size, which aligns closely with the typical experimental scale within MDC. Competing systems require substantially higher minimum slide numbers, making them unsuitable and leading to inefficient use of resources.\nIn addition, acquiring the Xenium system will strengthen MDC\u0027s national role by providing UK drug discovery organisations access to a capability that is not currently available within any UK based CRO. This avoids duplication with existing commercial provider and ensures MDC can offer new and complementary capabilities to the wider life sciences community.",
"procurementMethodRationaleClassifications": [
{
"id": "singleSuppliersTechnicalReasons"
}
],
"status": "complete",
"title": "Xenium Single-cell Spatial Transcriptomics/Proteomics Instrument for Medicines Discovery Catapult"
}
}